Mumbai: A total of 11 billion doses of Covid-19 vaccine are produced and sent to countries globally in 2021, which doubled the total volume of the global vaccine market in the pre-covid year, for routine immunization.
From Jab Covid-19, two Chinese vaccines – Sinovac and Sinopharm – corner stock volume of 21% and 19% (2.3 billion and 2.1 billion doses), while the share of the Indian Serum Institute (SII) stands at 13 % or 1.5 billion doses, according to the UNICEF year review.
In India alone, the use of the Covishield produced by SII is around 1.4 billion doses until now.
As with this, in the pre-covid era, the vaccine market for the largest global vaccine vaccine (based on volume) in 2019 – reached 1.5 billion doses, while for seasonal influenza, reaching 0.5 billion doses.
Furthermore, 5.5 billion vaccines used for routine immunization including 85 different vaccines for different diseases.
Data highlights injustice characterized by a very uneven global distribution of the Covid-19 vaccine.
High-income countries received nearly 200 doses per 100 residents compared with less than 20 doses per 100 residents in low-income countries.
Although the World Health Organization called for the moratorium on the Covid-19 Booster-19 Jab to the end of 2021, their government in rich countries increased dramatically at the end of the year to fight the Omicron variant.
In the future, the focus for the new vaccine supply agreement will be on the pediatric, booster and / or new variant vaccine, it adds.
Previously, 115 countries signed 515 supply agreements for 17.8 billion doses of covid-19 vaccine guaranteed in addition to 5.3 billion optional doses.
Rich countries have succeeded in securing large dose volumes by the end of 2020, while middle-income countries to the top signed a supply agreement with a pause of several months and at a much lower volume.
Down middle-income countries are only able to secure an increase in the number of doses through bilateral agreements from the second quarter of 2021 and so on, with the majority of the doses will only be several countries.
In less than a year since the first Covid-19 vaccine was introduced on the market, 33 different Jabs had been approved for use by at least one national supervisory authority, the data said.
Five vaccine manufacturers – Sinovac, Sinopharm, Pfizer / Bionthech, SII and AstraZeneca – together consist of 80% of the total covid vaccine market (based on volume).
Share the RNA Messenger Pfizer / Biontech vaccine reached 18% (2 billion doses) and AstraZeneca at 8% (0.9 billion) in global counting.